Synchronicity Pharma

About Synchronicity Pharma

Synchronicity Pharma is a pioneering biotechnology company focused on developing transformative therapies by leveraging the burgeoning understanding of circadian rhythm biology. The company operates in the pharmaceutical and biotechnology market, primarily serving patients with diseases influenced by the body's internal clock. Synchronicity Pharma's core business model revolves around the development and commercialization of novel therapeutics that modulate circadian clock genes, particularly through their Cryptochrome modulator programs. These programs enable the creation of clinical-stage compounds that safely target the core clock molecular machinery, offering new treatment avenues for a variety of disease areas.

The company generates revenue through the development and licensing of its proprietary compounds, as well as potential partnerships with larger pharmaceutical firms. Synchronicity Pharma's innovative approach positions it uniquely within the biotech industry, addressing unmet medical needs by focusing on the body's natural rhythms.